Literature DB >> 3262586

Production of an interleukin-1 inhibitor by cell line P388D1 murine macrophages stimulated with Haemophilus actinomycetemcomitans lipopolysaccharide.

T Nishihara1, T Koga, S Hamada.   

Abstract

Murine macrophages of the P388D1 cell line stimulated with lipopolysaccharide (LPS) from Haemophilus actinomycetemcomitans Y4 released an interleukin-1 (IL-1) inhibitor, as well as IL-1. Maximal IL-1 activity in culture supernatants was detected after 24 h of culture. On the other hand, IL-1 inhibitor activity reached a maximum level after 72 h of culture. An IL-1 inhibitor was partially purified from the culture supernatant of P388D1 cells stimulated with Y4 LPS for 72 h by ammonium sulfate precipitation, followed by Sephacryl S-200 gel chromatography. A 160-kilodalton peak inhibitory to IL-1 and a 14-kilodalton peak showing IL-1 activity were separated by Sephacryl S-200 column chromatography. The partially purified IL-1 inhibitor significantly suppressed the proliferation of C3H/HeJ murine thymocytes that had been induced with murine and human IL-1 in the presence of a submitogenic dose of concanavalin A. The IL-1 inhibitor more strongly suppressed human recombinant IL-1 beta than human recombinant IL-1 alpha. This inhibitory activity of the partially purified preparation was unaffected by the presence of trypsin inhibitor and the protease inhibitor aprotinin. The IL-1 inhibitor did not exhibit either IL-2 or IL-2 inhibitor activity. The inhibitor suppressed C3H/HeJ thymocyte proliferation induced by IL-1 in the presence of a saturated concentration of IL-2 instead of a suboptimal concentration of concanavalin A. These results indicate that prolonged culture of Y4 LPS-stimulated murine macrophages releases a specific inhibitor of IL-1.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3262586      PMCID: PMC259653          DOI: 10.1128/iai.56.11.2801-2807.1988

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  41 in total

1.  Long term culture of tumour-specific cytotoxic T cells.

Authors:  S Gillis; K A Smith
Journal:  Nature       Date:  1977-07-14       Impact factor: 49.962

2.  Biologic and biochemical activities of continuous macrophage cell lines P388D1 and J774.1.

Authors:  R Snyderman; M C Pike; D G Fischer; H S Koren
Journal:  J Immunol       Date:  1977-12       Impact factor: 5.422

3.  Biochemical relationship of thymocyte mitogenic factor and factors enhancing humoral and cell-mediated immune responses.

Authors:  J J Farrar; P L Simon; W J Koopman; J Fuller-Bonar
Journal:  J Immunol       Date:  1978-10       Impact factor: 5.422

4.  Preparation of lymphocyte-activating factor from continuous murine macrophage cell lines.

Authors:  L B Lachman; M P Hacker; G T Blyden; R E Handschumacher
Journal:  Cell Immunol       Date:  1977-12       Impact factor: 4.868

5.  Studies on the purification and structure-functional relationships of murine lymphocyte activating factor (Interleukin 1).

Authors:  S B Mizel
Journal:  Mol Immunol       Date:  1980-05       Impact factor: 4.407

6.  Components of mycobacteria and muramyl dipeptide with adjuvant activity induce lymphocyte activating factor.

Authors:  J J Oppenheim; A Togawa; L Chedid; S Mizel
Journal:  Cell Immunol       Date:  1980-03-01       Impact factor: 4.868

7.  Radioimmunologic determination of 15-keto-13,14-dihydro-PGE2: a method for its stable degradation product, 11-deoxy-15-keto-13,14-dihydro-11 beta, 16 xi-cyclo-PGE2.

Authors:  E Granström; F A Fitzpatrick; H Kindahl
Journal:  Methods Enzymol       Date:  1982       Impact factor: 1.600

8.  Black-pigmented Bacteroides species, Capnocytophaga species, and Actinobacillus actinomycetemcomitans in human periodontal disease: virulence factors in colonization, survival, and tissue destruction.

Authors:  J Slots; R J Genco
Journal:  J Dent Res       Date:  1984-03       Impact factor: 6.116

9.  The bone-resorbing activities in tissue culture of lipopolysaccharides from the bacteria Actinobacillus actinomycetemcomitans, Bacteroides gingivalis and Capnocytophaga ochracea isolated from human mouths.

Authors:  Y Iino; R M Hopps
Journal:  Arch Oral Biol       Date:  1984       Impact factor: 2.633

10.  Identification of a specific interleukin 1 inhibitor in the urine of febrile patients.

Authors:  Z Liao; R S Grimshaw; D L Rosenstreich
Journal:  J Exp Med       Date:  1984-01-01       Impact factor: 14.307

View more
  3 in total

1.  Mouse interleukin-1 receptor antagonist induced by Actinobacillus actinomycetemcomitans lipopolysaccharide blocks the effects of interleukin-1 on bone resorption and osteoclast-like cell formation.

Authors:  T Nishihara; Y Ohsaki; N Ueda; N Saito; G R Mundy
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

2.  An interleukin-1 inhibitor in gingival crevicular fluid of patients with chronic inflammatory periodontal disease.

Authors:  H Kabashima; K Maeda; H Iribe; K Yamashita; T Hirofuji; Y Iwamoto; M Aono
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

3.  Murine macrophage interleukin-1 release by capsularlike serotype-specific polysaccharide antigens of Actinobacillus actinomycetemcomitans.

Authors:  T Takahashi; T Nishihara; Y Ishihara; K Amano; N Shibuya; I Moro; T Koga
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.